TECH vs TFX · P/E 65, rev $1.22B vs P/E 2083, rev $3.05B
Bio-Techne Corp (TECH) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported TFX revenue for 2024-12-31 was $3.05B. Net income was $69.7M. Revenue was up 2.4% from 2023-12-31 to 2024-12-31. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the TECH and TFX stock pages for the full models.
Not investment advice.